Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs

Overview

Authors: Jordan Mazzola¹, Manuela Rosenfeld¹, Matthew Tucker¹, Jackson Wezeman¹, Warren Ladiges¹, Gerald Liao¹

University of Washington

Journal: Research square, pages rs.3.rs-9520102

Dates: published online 26 May 2026

Type: Research article · Language: English

License: CC BY

Identifiers: DOI · PMCID PMC13232416

Status: data only

Categories: genetics / omics (modality), mouse (organism)

Methods: Statistics

Keywords: aging, cognitive decline, GHK-Cu peptide, intraperitoneal delivery, intranasal delivery, RNA sequencing

Citations: 35 references in the paper

Abstract

Age-related cognitive decline (ARCD) is driven by conserved biological mechanisms of aging, yet no gerotherapeutic directly targets these processes in the brain. Glycyl-L-histidyl-L-lysine complexed with copper (GHK-Cu) is an endogenous peptide with regenerative and anti-inflammatory properties that declines with age. Whether its effects on cognitive aging depend on delivery route or exposure duration remains unclear. Aged C57BL/6J mice (20–21 months) received GHK-Cu (15 mg/kg) via short-term intraperitoneal (IP; 5 days) or longer-term intranasal (IN; 8 weeks) administration. Hippocampal-dependent escape learning was assessed using a spatial navigation task. Molecular effects were evaluated using hippocampal immunohistochemistry and bulk RNA sequencing. Differential gene expression was analyzed using DESeq2 with false discovery rate (FDR) correction, and pathway-level changes were assessed via gene set enrichment analysis (GSEA). IN GHK-Cu improved escape latency across Trials 2–4 in both sexes (P < 0.05), whereas IP dosing produced a transient improvement in males during Trial 2 (P < 0.05) without sustained effects or improvement in females. IN treatment increased synaptophysin in females (P < 0.001) and decreased GFAP in both sexes (P < 0.01), while IP treatment reduced TGF-β, GFAP, and MCP-1 in males (P < 0.05) and decreased p21 in females (P < 0.0001). Transcriptomic analysis revealed distinct molecular programs. IN GHK-Cu induced coordinated suppression of oxidative phosphorylation (male NES − 5.44, female NES − 4.20; FDR < 0.0001) and MYC target pathways (female NES − 4.31, FDR < 0.0001), with additional attenuation of PI3K-AKT-mTOR signaling in females (NES − 3.15, FDR = 0.062). In contrast, IP treatment activated oxidative phosphorylation (female NES 4.97, FDR < 0.001), DNA repair (NES 5.58, FDR < 0.001), and MYC targets (NES 4.34, FDR = 0.002), indicating engagement of acute stress-response and repair pathways. GHK-Cu improves hippocampal-dependent learning in aged mice through distinct biological modes: IP exposure activates repair and stress-response pathways, whereas IN delivery induces sustained suppression of growth and mitochondrial metabolic signaling associated with aging biology. These findings demonstrate that functional cognitive improvement can arise from divergent molecular states and identify administrative route and exposure duration as key determinants of gerotherapeutic response.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

bioproject:PRJNA1462979 — at NCBI BioProject; found in “Data availability statement.”

Data availability statement

The behavioral and histological data are available from the corresponding author on reasonable request. The RNA-sequencing data generated during the current study are available in the NCBI repository (accession PRJNA1462979: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1462979).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, pages, dates, 6 authors, 6 keywords, 34 references.

Cite

This paper

Mazzola, J., Rosenfeld, M., Tucker, M., Wezeman, J., Ladiges, W., & Liao, G. (2026). Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs. Research square, rs.3.rs-9520102.

BibTeX

@article{mazzola2026middle, author = {Mazzola, Jordan and Rosenfeld, Manuela and Tucker, Matthew and Wezeman, Jackson and Ladiges, Warren and Liao, Gerald}, title = {{Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs}}, journal = {Research square}, year = {2026}, month = may, pages = {rs.3.rs--9520102}, publisher = {Research Square}, issn = {2693-5015}, pmcid = {PMC13232416} }

RIS

TY - JOUR AU - Mazzola, Jordan AU - Rosenfeld, Manuela AU - Tucker, Matthew AU - Wezeman, Jackson AU - Ladiges, Warren AU - Liao, Gerald TI - Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs T2 - Research square J2 - Res Sq PY - 2026 DA - 2026/05/26 SP - rs.3.rs EP - 9520102 SN - 2693-5015 PB - Research Square LA - en ER -

CSL-JSON

{ "id": "pmcid:PMC13232416", "type": "article-journal", "title": "Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs", "container-title": "Research square", "author": [ { "family": "Mazzola", "given": "Jordan" }, { "family": "Rosenfeld", "given": "Manuela" }, { "family": "Tucker", "given": "Matthew" }, { "family": "Wezeman", "given": "Jackson" }, { "family": "Ladiges", "given": "Warren" }, { "family": "Liao", "given": "Gerald" } ], "container-title-short": "Res Sq", "page": "rs.3.rs-9520102", "PMCID": "PMC13232416", "ISSN": "2693-5015", "publisher": "Research Square", "language": "en", "issued": { "date-parts": [ [ 2026, 5, 26 ] ] } }

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.